Sensei Biotherapeutics, Inc.
- SNSE
- NASDAQ
- Biotechnology
- Cancer Immunotherapy
- Phage-Based Vaccines
$13.85
Today −22.28%Quote Jun 15, 2026, 08:00 PM UTC
+97.50%over the last month
Max drawdown −49.0%From 1-month high −0.7%3 months +8.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Sensei Biotherapeutics
Sensei Biotherapeutics, Inc. (SNSE) is a biopharmaceutical firm dedicated to discovering and advancing immunotherapies, primarily for cancer treatment. The company's innovative approaches include its proprietary ImmunoPhage platform.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
14
Market value
$78.2M
Approximate share count
Analyst target
$50.00
+261.0% from here
Resistance
$14.64
5.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SNSEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free